Recombinant DNA (genetic engineering): Overview
What it does
The job the technology does for people, in a short paragraph
Recombinant DNA lets scientists move a gene from one organism into another, so that a host such as a bacterium or a cultured cell makes a protein it would not make on its own. The first experiments succeeded in 1973, and the first product, human insulin, was approved in 1982 [1]. The method now underlies many biological medicines and genetically modified crops [1].
as of 2026-11-11
How it works
The working principle in plain words, step by step
Every living thing stores its instructions in DNA, written in the same four-letter code. That shared code is what makes the method possible: a human gene placed in a bacterium is read by the bacterium's own machinery. Special enzymes, first found in bacteria, cut DNA at particular places, and the cut pieces from different sources can be joined [1][3]. The joined DNA is carried into a host cell, which copies it each time it divides [1]. The cells read the gene and make its protein. For a medicine, the protein is then purified in licensed plants and each product is approved by regulators before use.
as of 2026-11-11
Key figures
The handful of numbers that size it up, each with its unit, year and source
| Figure | Value | Unit | Year | Source |
|---|---|---|---|---|
| People with type 2 diabetes who rely on insulin, more than | 60 | million people | 2021 | [5] |
| People with type 1 diabetes for whom insulin makes the disease manageable | 9 | million people | 2021 | [5] |
| Share of the insulin market held by three multinational companies, more than | 90 | % | 2021 | [5] |
| Possible saving from biosimilar insulins, more than | 25 | % | 2021 | [5] |
as of 2026-11-11. Insulin, the first recombinant medicine, is used as the clearest measure of reach; no world figure for all recombinant products was found.
Where it is used
The main places and products the technology is found in
- Medicines such as human insulin, growth hormone and many vaccines and antibodies
- Enzymes for food, detergents and industry
- Genetically modified crops
- Basic research in biology and medicine
- Gene therapy and gene editing research
as of 2026-11-11
Scale today
How much of it there is now: units in use, made each year and who uses it
- Users
- More than 60 million people with type 2 diabetes and about 9 million with type 1 depend on insulin [5]
- Unit
- people
- Year
- 2021
- Note
- Counts insulin users only, as a guide; no world count of all recombinant products was found.
as of 2026-11-11
Sources
- Herbert W. Boyer and Stanley N. Cohen Science History Institute
- The Nobel Prize in Physiology or Medicine 1978: summary Nobel Prize Outreach (nobelprize.org)
- New WHO report maps barriers to insulin availability and suggests actions to promote universal access World Health Organization, 2021